血压指南:超越简单目标

S. Harrap
{"title":"血压指南:超越简单目标","authors":"S. Harrap","doi":"10.1097/XCE.0000000000000066","DOIUrl":null,"url":null,"abstract":"Hypertension and blood pressure guidelines have developed incrementally over the years, keeping pace, and now outstripping, the clinical trials that have fuelled their opinions and recommendations. The focus has been very much on treatment thresholds and targets, so well suited to the medical model. However, the routine approach to blood pressure reduction in individuals of high cardiovascular risk, irrespective of their pressure and without a target, seem to slipped under the radar of the guidelines. It is time to rectify this significant oversight and take a broader view of treatment paradigms other than those based simply on targets. Cardiovasc Endocrinol 00:000–000 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.","PeriodicalId":72529,"journal":{"name":"Cardiovascular endocrinology","volume":"65 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2016-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blood pressure guidelines: beyond simple targets\",\"authors\":\"S. Harrap\",\"doi\":\"10.1097/XCE.0000000000000066\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hypertension and blood pressure guidelines have developed incrementally over the years, keeping pace, and now outstripping, the clinical trials that have fuelled their opinions and recommendations. The focus has been very much on treatment thresholds and targets, so well suited to the medical model. However, the routine approach to blood pressure reduction in individuals of high cardiovascular risk, irrespective of their pressure and without a target, seem to slipped under the radar of the guidelines. It is time to rectify this significant oversight and take a broader view of treatment paradigms other than those based simply on targets. Cardiovasc Endocrinol 00:000–000 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.\",\"PeriodicalId\":72529,\"journal\":{\"name\":\"Cardiovascular endocrinology\",\"volume\":\"65 1\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/XCE.0000000000000066\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/XCE.0000000000000066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

多年来,高血压和血压指南一直在逐步发展,与临床试验保持同步,现在已经超过了临床试验,这些临床试验为它们的观点和建议提供了支持。重点是治疗阈值和目标,因此非常适合医学模式。然而,对于心血管疾病高危人群的常规降压方法,无论他们的血压如何,也没有目标,似乎都被指南忽视了。现在是纠正这种重大疏忽的时候了,对治疗范例采取更广泛的看法,而不是仅仅以目标为基础。版权所有©2015威科集团健康有限公司版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Blood pressure guidelines: beyond simple targets
Hypertension and blood pressure guidelines have developed incrementally over the years, keeping pace, and now outstripping, the clinical trials that have fuelled their opinions and recommendations. The focus has been very much on treatment thresholds and targets, so well suited to the medical model. However, the routine approach to blood pressure reduction in individuals of high cardiovascular risk, irrespective of their pressure and without a target, seem to slipped under the radar of the guidelines. It is time to rectify this significant oversight and take a broader view of treatment paradigms other than those based simply on targets. Cardiovasc Endocrinol 00:000–000 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care. Oxford Diabetes Symposium 2017. Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males The association of vitamin D status and dietary calcium intake with individual components of the metabolic syndrome: a population-based study in Victoria, Australia Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1